Which entities associated with James N. Wilson were involved in the Corcept (CORT) share gifts?

The gifts involved entities including the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners. Additional indirect holdings are shown in the Pamela D. Wilson 2025 Grantor Retained Annuity Trust and the James N. Wilson 2025 Grantor Retained Annuity Trust.

Are the Corcept (CORT) share gifts by Wilson considered market sales?

No, the transactions are coded as bona fide gifts, not market sales. The Form 4 uses transaction code “G” with a transaction price of 0.0000 per share, indicating transfers without consideration rather than open-market selling activity.

Corcept director reports 910,078-share stock gifts

Corcept Therapeutics director James N. Wilson reported indirect gifts of company stock made through family entities.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Corcept Therapeutics director James N. Wilson reported indirect gifts of company stock made through family entities. Entities associated with Wilson, including a family trust and James and Pamela Wilson Family Partners, made bona fide gifts totaling 910,078 shares of Corcept common stock at no consideration.

Following these transactions, the James N. Wilson and Pamela D. Wilson Trust held 1,104,543 shares indirectly, and two 2025 Grantor Retained Annuity Trusts each held 200,000 shares. Wilson has voting power over certain shares via voting agreements but disclaims beneficial ownership except to the extent of his pecuniary interest.

Insider Trade Summary

910,078 shares gifted

Gift 5 txns

Insider WILSON JAMES N

Role Director

Type	Security	Shares	Price	Value
Gift	Common Stock	892,056	$0.00	$0.00
Gift	Common Stock	9,011	$0.00	$0.00
Gift	Common Stock	9,011	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 0 shares (Indirect, James and Pamela Wilson Family Partners); Common Stock — 1,104,543 shares (Indirect, James N. Wilson and Pamela D. Wilson Trust); Common Stock — 200,000 shares (Indirect, James N. Wilson 2025 Grantor Retained Annuity Trust); Common Stock — 200,000 shares (Indirect, Pamela D. Wilson 2025 Grantor Retained Annuity Trust)

Footnotes (2)

F1. Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
F2. Transfer of shares without consideration to the James N. Wilson and Pamela D. Wilson Trust.

Key Figures

Total shares gifted: 910,078 shares Large gift block: 892,056 shares Smaller gift blocks: 9,011 shares each +4 more

7 metrics

Total shares gifted 910,078 shares Aggregate bona fide gifts of common stock

Large gift block 892,056 shares Single bona fide gift entry of common stock

Smaller gift blocks 9,011 shares each Two bona fide gift entries of common stock

Trust holdings after gift 1,104,543 shares James N. Wilson and Pamela D. Wilson Trust post-transaction

Pamela Wilson 2025 GRAT 200,000 shares Indirect holding of Corcept common stock

James Wilson 2025 GRAT 200,000 shares Indirect holding of Corcept common stock

Gift price per share $0.0000 per share Bona fide gift transactions with no consideration

Key Terms

bona fide gift, Grantor Retained Annuity Trust, pecuniary interest, voting agreements, +1 more

5 terms

bona fide gift financial

"transaction code description is listed as "Bona fide gift" for several entries"

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

Grantor Retained Annuity Trust financial

"nature_of_ownership references the 2025 Grantor Retained Annuity Trusts for James and Pamela Wilson"

A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.

pecuniary interest financial

"footnote states Wilson disclaims beneficial ownership except to the extent of his pecuniary interest"

voting agreements financial

"footnote notes Wilson has voting power over certain shares pursuant to voting agreements"

A voting agreement is a legally binding deal where shareholders promise to cast their votes the same way on corporate matters, such as choosing directors or approving big transactions. Think of it like a neighborhood group agreeing to support the same candidate so they can decide how the block is run; for investors, these pacts can change who controls a company, influence strategy and risk, and affect the value and liquidity of shares.

indirect ownership financial

"ownership_type and ownership_code indicate indirect holdings through trusts and family partnerships"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Corcept Therapeutics (CORT) director James N. Wilson report on this Form 4?

James N. Wilson reported indirect bona fide gifts of Corcept common stock made through family entities totaling 910,078 shares. These are non-market transfers recorded as gifts rather than open-market sales or purchases, reflecting estate or family planning activity.

How many Corcept (CORT) shares were gifted in the reported transactions?

The filing shows gifts totaling 910,078 shares of Corcept common stock. These gifts occurred through multiple entries, including transfers of 892,056 shares and 9,011-share blocks, and are coded as bona fide gifts with a per-share price of zero.

How many Corcept (CORT) shares does the Wilson family trust hold after the gifts?

After the reported gifts, the James N. Wilson and Pamela D. Wilson Trust held 1,104,543 shares of Corcept common stock indirectly. This post-transaction balance comes from the Form 4 line item showing total shares following the bona fide gift transaction.

What indirect Corcept (CORT) holdings are shown for the Wilson Grantor Retained Annuity Trusts?

The filing shows 200,000 Corcept shares held indirectly in the Pamela D. Wilson 2025 Grantor Retained Annuity Trust and another 200,000 shares in the James N. Wilson 2025 Grantor Retained Annuity Trust. These entries are reported as holdings on the transaction date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/29/2026 - 05:56 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WILSON JAMES N

(Last)

(First)

(Middle)

C/O CORCEPT THERAPEUTICS INCORPORATED

101 REDWOOD SHORES PARKWAY

(Street)

REDWOOD CITY

CALIFORNIA

94065

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CORCEPT THERAPEUTICS INC [ CORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/27/2026		G		892,056	D	$0.00	9,011	I	James and Pamela Wilson Family Partners⁽¹⁾
Common Stock	05/27/2026		G⁽²⁾		9,011	D	$0.00	0	I	James and Pamela Wilson Family Partners⁽¹⁾
Common Stock	05/27/2026		G⁽²⁾		9,011	A	$0.00	1,104,543	I	James N. Wilson and Pamela D. Wilson Trust⁽¹⁾
Common Stock								200,000	I	James N. Wilson 2025 Grantor Retained Annuity Trust
Common Stock								200,000	I	Pamela D. Wilson 2025 Grantor Retained Annuity Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.

2. Transfer of shares without consideration to the James N. Wilson and Pamela D. Wilson Trust.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.

	/s/ Joseph Douglas Lyon, as attorney-in-fact for James N. Wilson	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR